Breakthrough Business Models: Drug Development for Rare and Neglected Diseases and Individualized Therapies: Workshop Summary (2009)

Chapter: 4 Diverse Funding Models

Unfortunately, this book can't be printed from the OpenBook. If you need to print pages from this book, we recommend downloading it as a PDF.

Visit NAP.edu/10766 to get more information about this book, to buy it in print, or to download it as a free PDF.
Previous Chapter: 3 The Food and Drug Administration's Orphan Drug Program
Page 19 Cite Bookmark
Suggested Citation: "4 Diverse Funding Models." Institute of Medicine. 2009. Breakthrough Business Models: Drug Development for Rare and Neglected Diseases and Individualized Therapies: Workshop Summary. Washington, DC: The National Academies Press. doi: 10.17226/12219.
Save
Cancel
Page 19
Page 20 Cite Bookmark
Suggested Citation: "4 Diverse Funding Models." Institute of Medicine. 2009. Breakthrough Business Models: Drug Development for Rare and Neglected Diseases and Individualized Therapies: Workshop Summary. Washington, DC: The National Academies Press. doi: 10.17226/12219.
Save
Cancel
Page 20
Page 21 Cite Bookmark
Suggested Citation: "4 Diverse Funding Models." Institute of Medicine. 2009. Breakthrough Business Models: Drug Development for Rare and Neglected Diseases and Individualized Therapies: Workshop Summary. Washington, DC: The National Academies Press. doi: 10.17226/12219.
Save
Cancel
Page 21
Page 22 Cite Bookmark
Suggested Citation: "4 Diverse Funding Models." Institute of Medicine. 2009. Breakthrough Business Models: Drug Development for Rare and Neglected Diseases and Individualized Therapies: Workshop Summary. Washington, DC: The National Academies Press. doi: 10.17226/12219.
Save
Cancel
Page 22
Page 23 Cite Bookmark
Suggested Citation: "4 Diverse Funding Models." Institute of Medicine. 2009. Breakthrough Business Models: Drug Development for Rare and Neglected Diseases and Individualized Therapies: Workshop Summary. Washington, DC: The National Academies Press. doi: 10.17226/12219.
Save
Cancel
Page 23
Page 24 Cite Bookmark
Suggested Citation: "4 Diverse Funding Models." Institute of Medicine. 2009. Breakthrough Business Models: Drug Development for Rare and Neglected Diseases and Individualized Therapies: Workshop Summary. Washington, DC: The National Academies Press. doi: 10.17226/12219.
Save
Cancel
Page 24
Page 25 Cite Bookmark
Suggested Citation: "4 Diverse Funding Models." Institute of Medicine. 2009. Breakthrough Business Models: Drug Development for Rare and Neglected Diseases and Individualized Therapies: Workshop Summary. Washington, DC: The National Academies Press. doi: 10.17226/12219.
Save
Cancel
Page 25
Page 26 Cite Bookmark
Suggested Citation: "4 Diverse Funding Models." Institute of Medicine. 2009. Breakthrough Business Models: Drug Development for Rare and Neglected Diseases and Individualized Therapies: Workshop Summary. Washington, DC: The National Academies Press. doi: 10.17226/12219.
Save
Cancel
Page 26
Page 27 Cite Bookmark
Suggested Citation: "4 Diverse Funding Models." Institute of Medicine. 2009. Breakthrough Business Models: Drug Development for Rare and Neglected Diseases and Individualized Therapies: Workshop Summary. Washington, DC: The National Academies Press. doi: 10.17226/12219.
Save
Cancel
Page 27
Page 28 Cite Bookmark
Suggested Citation: "4 Diverse Funding Models." Institute of Medicine. 2009. Breakthrough Business Models: Drug Development for Rare and Neglected Diseases and Individualized Therapies: Workshop Summary. Washington, DC: The National Academies Press. doi: 10.17226/12219.
Save
Cancel
Page 28
Page 29 Cite Bookmark
Suggested Citation: "4 Diverse Funding Models." Institute of Medicine. 2009. Breakthrough Business Models: Drug Development for Rare and Neglected Diseases and Individualized Therapies: Workshop Summary. Washington, DC: The National Academies Press. doi: 10.17226/12219.
Save
Cancel
Page 29
Page 30 Cite Bookmark
Suggested Citation: "4 Diverse Funding Models." Institute of Medicine. 2009. Breakthrough Business Models: Drug Development for Rare and Neglected Diseases and Individualized Therapies: Workshop Summary. Washington, DC: The National Academies Press. doi: 10.17226/12219.
Save
Cancel
Page 30
Page 31 Cite Bookmark
Suggested Citation: "4 Diverse Funding Models." Institute of Medicine. 2009. Breakthrough Business Models: Drug Development for Rare and Neglected Diseases and Individualized Therapies: Workshop Summary. Washington, DC: The National Academies Press. doi: 10.17226/12219.
Save
Cancel
Page 31
Page 32 Cite Bookmark
Suggested Citation: "4 Diverse Funding Models." Institute of Medicine. 2009. Breakthrough Business Models: Drug Development for Rare and Neglected Diseases and Individualized Therapies: Workshop Summary. Washington, DC: The National Academies Press. doi: 10.17226/12219.
Save
Cancel
Page 32
Page 33 Cite Bookmark
Suggested Citation: "4 Diverse Funding Models." Institute of Medicine. 2009. Breakthrough Business Models: Drug Development for Rare and Neglected Diseases and Individualized Therapies: Workshop Summary. Washington, DC: The National Academies Press. doi: 10.17226/12219.
Save
Cancel
Page 33
Page 34 Cite Bookmark
Suggested Citation: "4 Diverse Funding Models." Institute of Medicine. 2009. Breakthrough Business Models: Drug Development for Rare and Neglected Diseases and Individualized Therapies: Workshop Summary. Washington, DC: The National Academies Press. doi: 10.17226/12219.
Save
Cancel
Page 34
Page 35 Cite Bookmark
Suggested Citation: "4 Diverse Funding Models." Institute of Medicine. 2009. Breakthrough Business Models: Drug Development for Rare and Neglected Diseases and Individualized Therapies: Workshop Summary. Washington, DC: The National Academies Press. doi: 10.17226/12219.
Save
Cancel
Page 35
Page 36 Cite Bookmark
Suggested Citation: "4 Diverse Funding Models." Institute of Medicine. 2009. Breakthrough Business Models: Drug Development for Rare and Neglected Diseases and Individualized Therapies: Workshop Summary. Washington, DC: The National Academies Press. doi: 10.17226/12219.
Save
Cancel
Page 36
Page 37 Cite Bookmark
Suggested Citation: "4 Diverse Funding Models." Institute of Medicine. 2009. Breakthrough Business Models: Drug Development for Rare and Neglected Diseases and Individualized Therapies: Workshop Summary. Washington, DC: The National Academies Press. doi: 10.17226/12219.
Save
Cancel
Page 37
Page 38 Cite Bookmark
Suggested Citation: "4 Diverse Funding Models." Institute of Medicine. 2009. Breakthrough Business Models: Drug Development for Rare and Neglected Diseases and Individualized Therapies: Workshop Summary. Washington, DC: The National Academies Press. doi: 10.17226/12219.
Save
Cancel
Page 38
Page 39 Cite Bookmark
Suggested Citation: "4 Diverse Funding Models." Institute of Medicine. 2009. Breakthrough Business Models: Drug Development for Rare and Neglected Diseases and Individualized Therapies: Workshop Summary. Washington, DC: The National Academies Press. doi: 10.17226/12219.
Save
Cancel
Page 39
Page 40 Cite Bookmark
Suggested Citation: "4 Diverse Funding Models." Institute of Medicine. 2009. Breakthrough Business Models: Drug Development for Rare and Neglected Diseases and Individualized Therapies: Workshop Summary. Washington, DC: The National Academies Press. doi: 10.17226/12219.
Save
Cancel
Page 40
Page 41 Cite Bookmark
Suggested Citation: "4 Diverse Funding Models." Institute of Medicine. 2009. Breakthrough Business Models: Drug Development for Rare and Neglected Diseases and Individualized Therapies: Workshop Summary. Washington, DC: The National Academies Press. doi: 10.17226/12219.
Save
Cancel
Page 41
Next Chapter: 5 Strategies for Facilitating Sharing of Research Materials and Data
Subscribe to Emails from the National Academies
Stay up to date on activities, publications, and events by subscribing to email updates.